Subscribe Now

[hb-subscribe]

Trending News

T1D Exchange T1D Exchange T1D Exchange
  • Activity
    • 3 hours, 43 minutes ago
      Sarah Berry likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      My pump
    • 4 hours, 40 minutes ago
      Marty likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      One nice thing about a watch for readings is that, while it is normally redundant, you can be separated from your phone. For example, when you are in water.
    • 4 hours, 48 minutes ago
      Marty likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      I use both as you can’t do everything you want in one or the other
    • 5 hours, 47 minutes ago
      Kathy Hanavan likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      I selected “other” because my preference (smart watch, mobile phone, or pump screen) depends on circumstances. Watch for a quick and discrete view; pump if I’m preparing for a profile or activity adjustment or bolus, mobile phone if just a food bolus.
    • 5 hours, 51 minutes ago
      John Barbuto likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      I use both as you can’t do everything you want in one or the other
    • 6 hours, 53 minutes ago
      Gerald Oefelein likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      I use both as you can’t do everything you want in one or the other
    • 6 hours, 54 minutes ago
      Laurie B likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      I’m curious about the reasoning behind using a dedicated reader. Could someone please enlighten me?
    • 6 hours, 54 minutes ago
      Laurie B likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      I selected “other” because my preference (smart watch, mobile phone, or pump screen) depends on circumstances. Watch for a quick and discrete view; pump if I’m preparing for a profile or activity adjustment or bolus, mobile phone if just a food bolus.
    • 6 hours, 55 minutes ago
      mojoseje likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      For Minimed, the dedicated reader is the pump.
    • 6 hours, 55 minutes ago
      mojoseje likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      I chose "dedicated reader". That reader is my pump, a Minimed 780G.
    • 6 hours, 56 minutes ago
      Marthaeg likes your comment at
      If you use a continuous glucose monitor (CGM), where do you prefer to view your CGM readings?
      I use both as you can’t do everything you want in one or the other
    • 19 hours, 27 minutes ago
      KarenM6 likes your comment at
      How comfortable are you, on a scale of 1–5, with artificial intelligence (AI) being integrated into your diabetes technology?
      Sorry. I'm not sold on AI. I don't trust the people making it. There are too many reasons it could go wrong and be disasterous (just read the above comments). I'm not opposed to computers helping with things such as Control IQ, but when the computer starts doing the thinking, I think we've crossed the line. An aside: I've listened to AI music, and I think it sounds impersonal. It lacks a humanness. I don't find it pleasant to listen to. I've heard horror stories about AI being used by the military, with the end result being nuclear holocaust. I am a hard NO to AI. I gave it a "5".
    • 19 hours, 29 minutes ago
      KarenM6 likes your comment at
      How comfortable are you, on a scale of 1–5, with artificial intelligence (AI) being integrated into your diabetes technology?
      I believe that AI may very well become a great tool - but at this time it still makes too many errors for me to be confident in it.
    • 19 hours, 29 minutes ago
      KarenM6 likes your comment at
      How comfortable are you, on a scale of 1–5, with artificial intelligence (AI) being integrated into your diabetes technology?
      Here's my concern. I've used AI when meeting new clients to take notes of my meetings while I'm talking with the client. Ostensibly, this frees me up from having to jot down notes while talking - allowing me to give my full attention to the conversation. (Very good benefit of AI) Then, when reviewing the notes, AI literally fabricated scenarios that weren't discussed (AI Hallucinations are a very bad side effect). Not knowing when AI will fabricate a fact pattern gives me great concern that AI will fabricate a glucose reading and then act on that hallucination. AI has great potential, but it's not ready yet.
    • 1 day, 1 hour ago
      D-connect likes your comment at
      How well do you understand the details of your health insurance coverage?
      I have an MA in writing and lit, but gobbledegook is gobbledegook. The fancy term is obscurantism.
    • 1 day, 1 hour ago
      D-connect likes your comment at
      How well do you understand the details of your health insurance coverage?
      They change all the time. Generally not in a direction to improve my health, but to increase the money in their wallet.
    • 1 day, 1 hour ago
      D-connect likes your comment at
      How well do you understand the details of your health insurance coverage?
      At the risk of being overly simplistic, it boils down to: "Heads, you lose. Tails, You lose." ╰── ──╮
    • 1 day, 2 hours ago
      Ahh Life likes your comment at
      How well do you understand the details of your health insurance coverage?
      I have an MA in writing and lit, but gobbledegook is gobbledegook. The fancy term is obscurantism.
    • 1 day, 2 hours ago
      Ahh Life likes your comment at
      How well do you understand the details of your health insurance coverage?
      Extremely. I have a certificate in Medical Billing & Coding.
    • 1 day, 5 hours ago
      Kathy Hanavan likes your comment at
      How well do you understand the details of your health insurance coverage?
      "Slightly," I think, maybe. Insurance companies change their policies, constantly. Prescription coverage changes every time I look at it. Medicare is a huge question mark. Honestly, Health insurance has become a big money making business, for them. I get different answers every time I call, depending upon whom I am talking with. I say it's time for socialized medicine.
    • 1 day, 5 hours ago
      atr likes your comment at
      How well do you understand the details of your health insurance coverage?
      At the risk of being overly simplistic, it boils down to: "Heads, you lose. Tails, You lose." ╰── ──╮
    • 1 day, 6 hours ago
      TEH likes your comment at
      How comfortable are you, on a scale of 1–5, with artificial intelligence (AI) being integrated into your diabetes technology?
      Roughly half my lows are caused by my auto correct system now. I expect AI hallucinations to make it worse. I have enough hallucinations when I'm low and need non-hallucinatory help. We all need more info on this subject to make better decisions. As my favorite 80's AI robot (Johnny 5) said, "Need input."
    • 1 day, 6 hours ago
      TEH likes your comment at
      How comfortable are you, on a scale of 1–5, with artificial intelligence (AI) being integrated into your diabetes technology?
      I'm not comfortable for many reasons: 1) AI hasn't proven respects boundaries, quite the opposite, too many reports of AI tend to view its responsibilities and decisions as NOT mine; 2) the companies behind AI systems do likewise in not respecting my data as mine and jumble it in with their own; 3) AI systems haven't proven themselves as reliable parties regarding data and actions. There are many more; AI systems have a long way to go before I entrust one with dosing strategies while I'm awake, let alone while I'm asleep!
    • 1 day, 6 hours ago
      TEH likes your comment at
      How comfortable are you, on a scale of 1–5, with artificial intelligence (AI) being integrated into your diabetes technology?
      I’ve done a large 2 week focus group through Syracuse University on AI. I’ve also been watching shows on European news about AI and medical issues. AI still has too many glitches when it comes to medical issues.
    • 1 day, 6 hours ago
      TEH likes your comment at
      How well do you understand the details of your health insurance coverage?
      At the risk of being overly simplistic, it boils down to: "Heads, you lose. Tails, You lose." ╰── ──╮
    Clear All
Pages
    • T1D Exchange T1D Exchange T1D Exchange
    • Articles
    • Community
      • About
      • Insights
      • T1D Screening
        • T1D Screening How-To
        • T1D Screening Results
        • T1D Screening Resources
      • Donate
      • Join the Community
    • Quality Improvement
      • About
      • Collaborative
        • Leadership
        • Committees
      • Centers
      • Meet the Experts
      • Learning Sessions
      • Resources
        • Change Packages
        • Sick Day Guide
        • FOH Screener
        • T1D Care Plans
      • Portal
      • Health Equity
        • Heal Advisors
    • Registry
      • About
      • Recruit for the Registry
    • Research
      • About
      • Publications
      • COVID-19 Research
      • Our Initiatives
    • Partnerships
      • About
      • Industry Partnerships
      • Academic Partnerships
      • Previous Work
    • About
      • Team
      • Board of Directors
      • Culture & Careers
      • Annual Report
    • Join / Login
    • Search
    • Donate

    Did cost have a factor in deciding which diabetes technology devices you use? Share more in the comments about this process for you (or a loved one)!

    Home > LC Polls > Did cost have a factor in deciding which diabetes technology devices you use? Share more in the comments about this process for you (or a loved one)!
    Previous

    On a scale of 1-5, how satisfied are you with your current overall T1D care routine? (1 = the least satisfied, 5 = the most satisfied)

    Next

    Has your career path been influenced by living with T1D, for better or worse? Share in the comments more about your experiences about T1D and your career.

    Samantha Walsh

    Samantha Walsh has lived with type 1 diabetes for over five years since 2017. After her T1D diagnosis, she was eager to give back to the diabetes community. She is the Community and Partner Manager for T1D Exchange and helps to manage the Online Community and recruit for the T1D Exchange Registry. Prior to T1D Exchange, Samantha fundraised at Joslin Diabetes Center. She graduated from the University of Massachusetts with a Bachelors degree in sociology and early childhood education.

    Related Stories

    " At T1D Exchange, we’re proud to announce our Medical and Research Advisory Team — an accomplished group of leaders in endocrinology, research, and quality improvement. Together, they are redefining what’s possible in type 1 diabetes (T1D) care through rigorous data analysis, innovative research approaches, and real-world implementation. Their collective expertise is central to our mission of improving outcomes for all people living with T1D.  “We’re excited to be working with our advisors given their deep expertise across a broad range of areas in T1D,” said Dave Walton, CEO of T1D Exchange. “Their involvement magnifies our reach, knowledge, and impact. These advisors are shaping the future of diabetes care — driving innovation across research, clinical practice, and quality improvement.”    Meet the Medical & Research Advisory Team  The T1D Exchange Medical and Research Advisory Team brings together four leading endocrinologists, each offering a unique perspective and shared commitment to advancing T1D care:    Jenise Wong, MD, PhD Pediatric endocrinologist at UCSF Benioff Children’s Hospital and Professor of Pediatrics in the Division of Endocrinology at the University of California, San Francisco Focus areas: Diabetes technology adoption and usability; health equity and access to care and technology; community-based and peer-support interventions; culturally responsive care          Jennifer Sherr, MD, PhD Pediatric endocrinologist at Yale Medicine and Professor of Pediatrics in the Division of Endocrinology at Yale School of Medicine in New Haven, Connecticut Focus areas: Clinical trials in diabetes technology (CGM and AID systems), disease-modifying treatments and immunotherapies, and emerging technologies and medications, including continuous ketone monitoring and nasal glucagon     Viral Shah, MD Adult endocrinologist at Indiana University Health and Professor of Medicine in the Division of Endocrinology and Metabolism at Indiana University School of Medicine in Indianapolis, Indiana Focus areas: Diabetes technology and adjunctive therapy trials; translational and data-driven research; T1D complications and bone health         Nestoras Mathioudakis, MD, MHS Adult endocrinologist at Johns Hopkins Medicine and Associate Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland Focus areas: AI-driven clinical support tools; EMR-based data analytics for clinical decision making; data-driven quality improvement; health equity in T1D care        This accomplished team’s expertise spans adult and pediatric endocrinology, research, and quality improvement affiliated with leading institutions nationwide. Collectively, they have authored over 500 diabetes publications and secured research funding from organizations such as the National Institutes of Health, Helmsley Charitable Trust, the American Diabetes Association, and Breakthrough T1D — while remaining actively engaged in both clinical care and research.  “These individuals represent an impressive body of work while remaining deeply involved in the day-to-day realities of diabetes care,” said Walton. Their expertise covers the full spectrum of T1D care — from AI and predictive analytics to complication prevention, automated insulin delivery, continuous glucose and ketone monitoring, GLP-1 treatments, health equity, mental health, autoantibody screening, and disease prevention.    Turning insight into impact  The team’s work goes beyond research, focusing on translating insights into real-world practice. By leveraging data to scale best practices, the goal is to drive meaningful, measurable change across clinics and communities.  “Our advisors will help to extend our impact — whether through QI strategy, research innovation, funding opportunities, or new data-driven solutions,” said Walton. “We want to take what’s working at individual centers and spread that as broadly as possible.”   He added, “As a Collaborative, we’re also focused on advanced population health strategies such as exploring predictive data models to identify risks earlier and intervene before complications even begin to happen.”    The power of the T1D Exchange Quality Improvement Collaborative  Central to this work is the T1D Exchange Quality Improvement Collaborative (T1DX-QI) — a nationwide network of clinics working together to improve care through shared data, benchmarking, and evidence-based practices.  “I’m thrilled to serve as a Medical Advisor for T1D Exchange, because I’ve seen firsthand the impact this network can have on patient care,” said Dr. Nestoras Mathioudakis. “T1D Exchange is the premier organization for quality improvement in type 1 diabetes, with unparalleled assets like a large EHR database and robust patient registry.”  He added that he is excited to apply his expertise in EHR research and big data analytics to generate real-world evidence across diagnosis, management, and outcomes.  Dr. Viral Shah echoed that perspective, reflecting on T1DX-QI's evolution: “I have been involved with T1D Exchange since its early days and have had the privilege of witnessing how it has transformed the quality of diabetes care across the United States. I’m delighted to return as a Medical Advisor.”  He emphasized the importance of accelerating impact. “I look forward to working closely with the team to accelerate the evidence generation and to help translate these insights to improve patient care.”   Dr. Jenise Wong highlighted the visible impact of T1DX-QI on the delivery of care. "I’m truly honored and grateful to be working with T1D Exchange as a Medical Advisor. T1DX-QI is a remarkable resource for centers that are using continuous process improvement to improve the quality of care for people living with diabetes.”  “Diabetes centers working with T1DX –QI have done amazing work using QI methodology to make care accessible and equitable for all people with diabetes,” she said. “It’s inspiring to be a part of a collaborative in which centers have been creative and thoughtful with initiatives to address individual and systemic challenges to care, improving clinical outcomes as well as the patient experience."  Looking ahead, Dr. Sherr highlighted the opportunity to build on the existing strong foundation. “I’m very excited to be working as a Medical Advisor for T1D Exchange,” she said. “It’s a privilege to help shape what comes next for a group that’s already doing such impactful work.”  “Sharing what’s happening in clinical practice, benchmarking across centers, and understanding outcomes is how we figure out what’s working, what’s not, and where we go next,” she said.      The future of T1D care   With this team’s vision and expertise, T1D Exchange is positioned to accelerate progress in T1D care — bridging research and real-world practice to drive meaningful, measurable impact.  Together, we look forward to advancing innovation and improving outcomes for everyone affected by type 1 diabetes.   "

    4 days ago  
    Meet the Expert

    Meet the Expert: Improving Diabetes Care Through Precision Medicine 

    Jewels Doskicz, 1 week ago 8 min read  
    Meet the Expert

    Meet the Expert: Bridging Research, Technology, and Real-World Care 

    Jewels Doskicz, 2 weeks ago 9 min read  
    Insulin & Meds

    Ask the Expert: Diana Isaacs on Benefits, Risks, and Real-World Use of GLP-1s in T1D 

    Jewels Doskicz, 2 weeks ago 6 min read  
    Meet the Expert

    Meet the Expert: Advancing Equity, Improving Outcomes, and Reducing the Burden of T1D 

    Jewels Doskicz, 1 month ago 8 min read  
    Our team

    Spotlight on T1DX-QI: Clinical Leadership Committee 

    Jewels Doskicz, 2 months ago 6 min read  

    47 Comments

    1. Lenora Ventura

      When fighting to get my 1st insulin pump, the major battle was the prior authorization required by my then “HMO”. That was in 1998. I couldn’t have afforded the cash price if my health insurance didn’t cover. A lot has changed in the past 20+ years. No longer a young college student along with studies proving the effectiveness of the therapy insulin pumps provide, getting approved is no longer a hurdle.

      2 years ago Log in to Reply
    2. Janice B

      There are many factors in choosing new technologies- cost is just one aspect

      3
      2 years ago Log in to Reply
    3. Gary Rind

      never have had a pump so I haven’t dug into the costs but I’ve heard that they are quite expensive which obviously is a big negative for me.

      2 years ago Log in to Reply
    4. Shelly Smith

      I answered “other” because the initial cost wasn’t so much the main idea but if it was covered by my insurance. Thankfully they covered the technology I thought was best for me!

      1
      2 years ago Log in to Reply
    5. Yaffa Steubinger

      I answered ‘no’ because my insurance pays 100%, even before meeting my annual deductible, for my tech devices.

      2 years ago Log in to Reply
    6. Patrick Burner

      Not anymore. Fifteen years ago I was purchasing in bulk vials from Canada and even changed insulin types.

      2 years ago Log in to Reply
    7. Sarah Berry

      I make sure insurance covers the technology

      2 years ago Log in to Reply
    8. luljeta plakolli

      I live in Kosovo where the overall diabetes management is not at a satisfactory level. There are no CGMs here. As a non-EU member, we do not have access to such a technology. This is an op-ed I have written lately on this (it is in Albanian but you can have it translated): https://sbunker.net/op-ed/91842/realiteti-i-hidhur-i-menaxhimit-te-diabetit-ne-kosove/
      As a result, CGMs and insulin pumps are not available and one has to buy them from abroad which adds to the costs, plus that there is a constant stress that even if you order them online, you are not going to receive them regularly on time. Periodically, there are CGMs available for sale, but these are either old models and cost a lot. We do not have public health insurance in our country, whereas private health insurance companies do not cover these (as a pre-existing condition). So, all in all, yes the cost had a factor in my and many other patients’ decisions about which diabetes technology devices we use. Consequently, I use old school blood glucose meter.

      2
      2 years ago Log in to Reply
      1. Kathy Hanavan

        This is really an unfortunate situation Luljeta and it makes me more grateful to have what we have in the US IF you have insurance. Interestingly, my brother lives in Kosovo ( works at NATO). How do I translate your op-ed? Thanks!

        2 years ago Log in to Reply
    9. dholl62@gmail.com

      Cost didn’t have a factor but it depended on my insurance and what device I was able to use

      1
      2 years ago Log in to Reply
    10. Meghan Larson

      Yes- I went with what is on the formulary. Not what I wanted but it works.

      2 years ago Log in to Reply
    11. lenglish@cimginc.com

      When looking for new pump I had to consider what Medicare would cover – I will be 65 soon.

      1
      2 years ago Log in to Reply
    12. Karen Tay

      I would prefer to have an OmniPod but it’s too expensive under Medicare because the company has it under Pharmacy. The cost than puts me into the “donut hole” by March. After that, I have to pay way too much out of pocket.
      But I have to say I’m very happy with my A1C results with the T slim Tandem IQ
      But I prefer not having the tubing to deal with.

      1
      2 years ago Log in to Reply
      1. john36m

        I’m in the same boat!

        2 years ago Log in to Reply
    13. William Ervin

      I don’t have insurance. After using a Minimed pump for several years, I wanted to try the Omnipod. It is extremely expensive. I ended up buying the Tandem tslim. I will also be changing from Dexcom to Freestyle Libre 2.5 now that it is compatible with my pump.

      2 years ago Log in to Reply
    14. Lawrence S.

      I may have answered incorrectly. I said “yes” because cost is a factor in just about every decision I make. However, my health insurance covers my technological devices. But, I wouldn’t order something that was too expensive for me to pay.

      2 years ago Log in to Reply
    15. Melissa Childers

      Insurance stopped paying for Medtronic 670G sensor, so switched to Dexcom G6 for coverage, and when pump warranty expired, switched to Tandem Control IQ for algorithm pumping.

      1
      2 years ago Log in to Reply
    16. Tina Roberts

      No. No calibrating sensors and no tubing did!!! God has always provided enough money for what my family needs. Not wants, but needs. We are so blessed.

      2 years ago Log in to Reply
    17. Marty

      I’m very lucky that Medicare + supplemental insurance completely covers all of the devices that I want to use. I didn’t have to change anything devise-wise when I turned 65.

      1
      2 years ago Log in to Reply
    18. Seth Johnson

      My insurance covers next to nothing as far as diabetes devices goes. So I have to pay full price to use the libre 3 system which is significantly cheaper than any of the other options. I can’t afford a pump either so I do MDI.

      2 years ago Log in to Reply
    19. Natalie Daley

      My insurance covers Libre sensors completely but not Dexcom … Libre is what I’m using.

      2 years ago Log in to Reply
    20. Mary Boudousquie

      I would love a tubeless pump like Omnipod but Medicare won’t pay for it under part B as they do tubed pumps.

      2 years ago Log in to Reply
    21. MT

      Monthly pump supplies were expensive even with my private insurance. Switched back to MDI and couldn’t be happier. Great A1Cs and no tubing! My sleep is better without a pump. So glad I switched back to MDI.

      2 years ago Log in to Reply
    22. Bob Durstenfeld

      I said no, but not because I didn’t consider the cost. It always has an impact on our budget. But because managing my diabetes is a priority that forces compromise elsewhere.

      2
      2 years ago Log in to Reply
    23. David Hedeen

      No, you can’t put a price on better diabetic care

      2 years ago Log in to Reply
      1. cynthia jaworski

        Unless you simply do not have the funds.

        2
        2 years ago Log in to Reply
    24. Amanda Barras

      Back in 2007, yes. Now, no.
      2007 – first pump but insurance didn’t pay anything towards CGM. That was $ 500 out of pocket plus supplies monthly to add that piece of functionality. Wasn’t until 2012 that I had insurance that would cover 80% of CGM. Now, I have 2 insurances and everything is covered 100%.

      2 years ago Log in to Reply
    25. Joindy23

      I’m well-controlled with MDI & know that switching to an insulin pump would increase costs & force use of a mail order medical supply company which is a huge hassle compared with a local pharmacy. This is one big reason I’m not using an insulin pump.

      1
      2 years ago Log in to Reply
    26. BOldfield

      Insurance decided that for me

      2 years ago Log in to Reply
    27. Sue Compo

      Medicare dictates what technology I use in addition to what kind of insulin I use.

      2 years ago Log in to Reply
    28. cynthia jaworski

      I high start-up cost, as for pumps or Dexcom, had ooten deterred me from giving new technologies a try. High prices made it feel like a large commitment for something I had mixed feelings about.
      When the more affordable Libre became available, I jumped on the opportunity. Happy about that choice!

      2 years ago Log in to Reply
    29. Jackie Vatsend

      My health insurance covers my insulin but barely makes a dent in the expense for my pump and CGM supplies. It’s a big expense for me. I will probably have to return to MDI therapy. Very disappointed.

      2 years ago Log in to Reply
      1. Anita Stokar

        🙁

        2 years ago Log in to Reply
    30. Karen DeVeaux

      On Medicare the CGM is free so I use that, whereas testing strips cost. I plan to use a pump, but I have to unenroll from my Part D plan first. $500 with Part D but free if I just have Part B.

      2 years ago Log in to Reply
    31. Kim Davis

      My endocrinologist said Tandem T Sim X2 IQ so I went with his advice

      2 years ago Log in to Reply
    32. TomH

      I’m fortunate to have good insurance and coverage, had I not the answer might well be different!

      1
      2 years ago Log in to Reply
    33. Mick Martin

      I selected “No”, but that was for me. I live in the UK (United Kingdom of Great Britain and Northern Ireland) where my diabetes supplies are paid for by our NHS (National Health System), which is funded via direct taxation of all working people that earn more than a set amount.

      As I was the first person, in the area that I live, to start using ‘pump technology’, my endocrinologist had to justify the expense to ‘the money handlers’, which he was able to do by comparing the costs of my repeated hospital admissions to what it would cost to furnish me with a pump and related supplies. Even now, some 30 years later, justification has to be made to ‘the money handlers’ when ‘new patients’ are deemed ‘fit’ to try pump technology, even though our NICE (National Institute for Clinical Excellence) has stated that many more patients should be considered for pump technology.

      2 years ago Log in to Reply
    34. Janis Senungetuk

      YES, but I answered “other”. Cost prevented me from getting a pump much earlier in my journey with T1D. I waited 62 years before purchasing a pump. After learning that I could apply for financial assistance from Animas, I was able to start pump therapy with their Animas Vibe pump. Two years later the company folded and I was again searching for a way to purchase a pump. At that point I had both primary and secondary insurance coverage. That’s where the “other” answer fits. I decided that I wanted a pump that would pair with a CGM and use AID to lessen my 24/7 burden. Tandem t:slim X2 offered that, but Medicare , my secondary insurance, would not cover the 20% remaining after primary coverage because my Animas pump was only 2 years old. That $900+ amount was a large portion of my savings, but because I was unwilling to return to MDI for the length of time remaining before Medicare would pay, I went ahead and paid the balance out-of-pocket. Using Control IQ has made a tremendous difference over the past 3+ years AND the $940 I paid was later refunded when Medicare ruled against Edwards (the DME supplier) for double billing.

      2 years ago Log in to Reply
    35. Kristi Warmecke

      I answered yes, to some extent. As long as Medicare covers it, I’m good.

      2
      2 years ago Log in to Reply
    36. ConnieT1D62

      No. I have been fortunate and have always made sure I had user friendly insurance coverage while I was covered by employers. Now I have a comprehensive Medicare Advantage plan and it covers everything I need except Baqsimi (nasal glucagon) which I prefer to have on hand to treat potential emergency episodes of severe hypoglycemia. I pay $180 out of pocket once a year to have a supply on hand.

      However, a T1 diabetes sister friend who gets refills for a $10.00 co-pay with her Medicare Advantage plan (she lives in another town and county in my state) sends me some from her excess supply. We have also helped each other out with sensors, pump supplies and other diabetes self-care supplies when mail order shipments are delayed.

      2 years ago Log in to Reply
    37. Eva

      Insulin pumps should be the standard of care for all type 1 diabetics. Why are the manufacturers of these devices are so greedy? I had a minimed 506 for over 10 years. It was built like a freakin’ brick and reliable. These days the devices are made so cheaply. They break if you blow on them hard. It’s a such a shame this question even needs to be asked.

      2 years ago Log in to Reply
    38. Jeff Balbirnie

      Cost is not THE sole and governing factor re: all our supplies and technology. If I cannot AFFORD it, I cannot USE it.

      2 years ago Log in to Reply
    39. Mike Plante

      Yes, I would have liked to remain on Omnipod but they stopped distributing their only version available via DME (Eros/Classic) so I switched back to Medtronic instead of having to pay for DASH via Pharmacy.

      2 years ago Log in to Reply
    40. Kathleen Juzenas

      Yes. I chose Tandem because it’s covered by Medicare Part B, so that with my supplemental plan, all expenses are paid. If I had chosen OmniPod, it would’ve gone through Medicare Part D and I would’ve had to pay co-pays out of pocket. My supplemental plan covers only items covered by Medicare Part B.

      2 years ago Log in to Reply
    41. A Montalbano

      We are fortunate to be able to cover the huge out of pocket costs at the beginning of year to get the supplies and medicines that works best for him. This is a HUGE equity issue and encourage everyone to message their legislators to be more inclusive/less barriers to obtaining CGMs and pumps on Medicaid and Medicare.

      2 years ago Log in to Reply
    42. Bonnie Lundblom

      My endocrinologist plays a part in my decisions about managing my T1D; my pump will be 5 years old in June and I’ve heard that Medicare will replace insulin pumps after 5 years. My endocrinologist said to stay with my Tandem Tslimx2 pump. This week I also started using the Dexcom CGM 7 and so far it’s been great and more accurate than the CGM 6 was.

      2 years ago Log in to Reply
    43. PamK

      I took into consideration what brand(s) my insurance would cover. So, I answered Yes because of this. My out of pocket was not a consideration though.

      2 years ago Log in to Reply

    Did cost have a factor in deciding which diabetes technology devices you use? Share more in the comments about this process for you (or a loved one)! Cancel reply

    You must be logged in to post a comment.




    101 Federal Street, Suite 440
    Boston, MA 02110
    Phone: 617-892-6100
    Email: admin@t1dexchange.org

    Privacy Policy

    Terms of Use

    Follow Us

    • facebook
    • twitter
    • linkedin
    • instagram

    © 2024 T1D Exchange.
    All Rights Reserved.

    © 2023 T1D Exchange. All Rights Reserved.
    • Login
    • Register

    Forgot Password

    Registration confirmation will be emailed to you.

    Skip Next Finish

    Account successfully created.

    Please check your inbox and verify your email in the next 24 hours.

    Your Account Type

    Please select all that apply.

    I have type 1 diabetes

    I'm a parent/guardian of a person with type 1 diabetes

    I'm interested in the diabetes community or industry

    Select Topics

    We will customize your stories feed based on what you select here.

    [userselectcat]

    We're preparing your personalized page.

    This will only take a second...

    Search and filter

    [searchandfilter slug="sort-filter-post"]